199 related articles for article (PubMed ID: 37964795)
21. Structural Bases of Atypical Whisker Responses in a Mouse Model of CDKL5 Deficiency Disorder.
Pizzo R; Lamarca A; Sassoè-Pognetto M; Giustetto M
Neuroscience; 2020 Oct; 445():130-143. PubMed ID: 31472213
[TBL] [Abstract][Full Text] [Related]
22. Dynamic m(6)A mRNA methylation directs translational control of heat shock response.
Zhou J; Wan J; Gao X; Zhang X; Jaffrey SR; Qian SB
Nature; 2015 Oct; 526(7574):591-4. PubMed ID: 26458103
[TBL] [Abstract][Full Text] [Related]
23. The 5' untranslated region of the human T-cell lymphotropic virus type 1 mRNA enables cap-independent translation initiation.
Olivares E; Landry DM; Cáceres CJ; Pino K; Rossi F; Navarrete C; Huidobro-Toro JP; Thompson SR; López-Lastra M
J Virol; 2014 Jun; 88(11):5936-55. PubMed ID: 24623421
[TBL] [Abstract][Full Text] [Related]
24. Behavioral impulsivity is associated with pupillary alterations and hyperactivity in CDKL5 mutant mice.
Viglione A; Sagona G; Carrara F; Amato G; Totaro V; Lupori L; Putignano E; Pizzorusso T; Mazziotti R
Hum Mol Genet; 2022 Nov; 31(23):4107-4120. PubMed ID: 35861639
[TBL] [Abstract][Full Text] [Related]
25. Impaired binding of standard initiation factors eIF3b, eIF4G and eIF4B to domain V of the live-attenuated coxsackievirus B3 Sabin3-like IRES--alternatives for 5'UTR-related cardiovirulence mechanisms.
Souii A; Gharbi J; Ben M'hadheb-Gharbi M
Diagn Pathol; 2013 Sep; 8():161. PubMed ID: 24063684
[TBL] [Abstract][Full Text] [Related]
26. AMPA Receptor Dysregulation and Therapeutic Interventions in a Mouse Model of CDKL5 Deficiency Disorder.
Yennawar M; White RS; Jensen FE
J Neurosci; 2019 Jun; 39(24):4814-4828. PubMed ID: 30952813
[TBL] [Abstract][Full Text] [Related]
27. CDKL5 deficiency disorder in males: Five new variants and review of the literature.
Siri B; Varesio C; Freri E; Darra F; Gana S; Mei D; Porta F; Fontana E; Galati G; Solazzi R; Niceta M; Veggiotti P; Alfei E
Eur J Paediatr Neurol; 2021 Jul; 33():9-20. PubMed ID: 33989939
[TBL] [Abstract][Full Text] [Related]
28. CDKL5 deficiency in forebrain glutamatergic neurons results in recurrent spontaneous seizures.
Wang HT; Zhu ZA; Li YY; Lou SS; Yang G; Feng X; Xu W; Huang ZL; Cheng X; Xiong ZQ
Epilepsia; 2021 Feb; 62(2):517-528. PubMed ID: 33400301
[TBL] [Abstract][Full Text] [Related]
29. CDKL5 deficiency causes epileptic seizures independent of cellular mosaicism.
Takahashi S; Takeguchi R; Tanaka R; Fukuoka M; Koike T; Ohtani H; Inoue K; Fukuda M; Kurahashi H; Nakamura K; Tominaga K; Matsubayashi T; Itoh M; Tanaka T
J Neurol Sci; 2022 Dec; 443():120498. PubMed ID: 36417806
[TBL] [Abstract][Full Text] [Related]
30. Treatment with FRAX486 rescues neurobehavioral and metabolic alterations in a female mouse model of CDKL5 deficiency disorder.
Fuchs C; Cosentino L; Urbinati C; Talamo MC; Medici G; Quattrini MC; Mottolese N; Pietraforte D; Fuso A; Ciani E; De Filippis B
CNS Neurosci Ther; 2022 Nov; 28(11):1718-1732. PubMed ID: 35932179
[TBL] [Abstract][Full Text] [Related]
31. Migration of Small Ribosomal Subunits on the 5' Untranslated Regions of Capped Messenger RNA.
Shirokikh NE; Dutikova YS; Staroverova MA; Hannan RD; Preiss T
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31510048
[TBL] [Abstract][Full Text] [Related]
32. sST2 translation is regulated by FGF2 via an hnRNP A1-mediated IRES-dependent mechanism.
Kunze MM; Benz F; Brauß TF; Lampe S; Weigand JE; Braun J; Richter FM; Wittig I; Brüne B; Schmid T
Biochim Biophys Acta; 2016 Jul; 1859(7):848-59. PubMed ID: 27168114
[TBL] [Abstract][Full Text] [Related]
33. Site-specific abnormalities in the visual system of a mouse model of CDKL5 deficiency disorder.
Lupori L; Sagona G; Fuchs C; Mazziotti R; Stefanov A; Putignano E; Napoli D; Strettoi E; Ciani E; Pizzorusso T
Hum Mol Genet; 2019 Sep; 28(17):2851-2861. PubMed ID: 31108505
[TBL] [Abstract][Full Text] [Related]
34. Functional and Structural Impairments in the Perirhinal Cortex of a Mouse Model of CDKL5 Deficiency Disorder Are Rescued by a TrkB Agonist.
Ren E; Roncacé V; Trazzi S; Fuchs C; Medici G; Gennaccaro L; Loi M; Galvani G; Ye K; Rimondini R; Aicardi G; Ciani E
Front Cell Neurosci; 2019; 13():169. PubMed ID: 31114483
[TBL] [Abstract][Full Text] [Related]
35. Cyclin-Dependent Kinase-Like 5 (CDKL5): Possible Cellular Signalling Targets and Involvement in CDKL5 Deficiency Disorder.
Katayama S; Sueyoshi N; Inazu T; Kameshita I
Neural Plast; 2020; 2020():6970190. PubMed ID: 32587608
[TBL] [Abstract][Full Text] [Related]
36. The stem-loop region of the tobacco psbA 5'UTR is an important determinant of mRNA stability and translation efficiency.
Zou Z; Eibl C; Koop HU
Mol Genet Genomics; 2003 Jun; 269(3):340-9. PubMed ID: 12690442
[TBL] [Abstract][Full Text] [Related]
37. A framework for understanding quality of life domains in individuals with the CDKL5 deficiency disorder.
Tangarorang J; Leonard H; Epstein A; Downs J
Am J Med Genet A; 2019 Feb; 179(2):249-256. PubMed ID: 30561084
[TBL] [Abstract][Full Text] [Related]
38. Rescue of prepulse inhibition deficit and brain mitochondrial dysfunction by pharmacological stimulation of the central serotonin receptor 7 in a mouse model of CDKL5 Deficiency Disorder.
Vigli D; Rusconi L; Valenti D; La Montanara P; Cosentino L; Lacivita E; Leopoldo M; Amendola E; Gross C; Landsberger N; Laviola G; Kilstrup-Nielsen C; Vacca RA; De Filippis B
Neuropharmacology; 2019 Jan; 144():104-114. PubMed ID: 30326240
[TBL] [Abstract][Full Text] [Related]
39. CDKL5 deficiency predisposes neurons to cell death through the deregulation of SMAD3 signaling.
Fuchs C; Medici G; Trazzi S; Gennaccaro L; Galvani G; Berteotti C; Ren E; Loi M; Ciani E
Brain Pathol; 2019 Sep; 29(5):658-674. PubMed ID: 30793413
[TBL] [Abstract][Full Text] [Related]
40. CDKL5 Deficiency Disorder-A Complex Epileptic Encephalopathy.
Jakimiec M; Paprocka J; Śmigiel R
Brain Sci; 2020 Feb; 10(2):. PubMed ID: 32079229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
